WHAT WE DO
The Research and Development Directorate provides science, technology, and capability development investments that maintain the U.S. military’s technological superiority in countering weapons of mass destruction & emerging threats, mitigate the risks of technical surprise, and respond to the warfighters’ urgent technical requirements.
VISION
Be the recognized leaders for technical innovation to counter WMD and emerging threats - we deliver innovative solutions that meet current mission requirements in a timely manner, and we anticipate and prepare for emerging and future threats with a balance of fundamental and applied research across the portfolio.
UPCOMING EVENTS AND RECENT ACTIVITY
THE 2022 CBD S&T CONFERENCE
The Chemical and Biological Defense Science & Technology (CBD S&T) Conference brings together the most innovative and influential chemical and biological defense community members from around the world to share insights and collaborative ideations on the pressing chem-bio threats of tomorrow.
Join the Defense Threat Reduction Agency’s (DTRA) Chemical and Biological Technologies Department, in its role as the Joint Science and Technology Office (JSTO) for the Chemical and Biological Defense Program, as we explore change-making concepts in the chem-bio defense landscape.
The 2022 CBD S&T Conference will be held December 6-9, 2022, at the Moscone Center in San Francisco, California.
Visit the Conference Website for More Information »
THE DEFENSE THREAT REDUCTION INFORMATION ANALYSIS CENTER (DTRIAC)
DTRIAC is the key Department of Defense source of information and analysis on nuclear and conventional weapons-related topics. Sponsored by the Defense Threat Reduction Agency, DTRIAC has major reference collections of documents, photographic data, and films and can search, retrieve and perform analyses on DTRA-internal and community-wide nuclear/conventional weapons phenomena, effects and technology matters and related nuclear/conventional technology transfer applications.
JOINT SCIENCE AND TECHNOLOGY OFFICE (JSTO) IN THE NEWS
